Latest Breaking News On - Ifpma - Page 1 : comparemela.com

Transcripts For BBCNEWS Business 20240620

robert wood, chief uk economist, pantheon macroeconomics. itjoins me now. no change expected today, why not? it joins me now. no change expected today, why not? good mornin: expected today, why not? good morning why expected today, why not? good morning why not? expected today, why not? good morning why not? inflation - expected today, why not? good morning why not? inflation is i morning why not? inflation is just back to the bank of england 2% target for top within that headline inflation, inflation with services, eating out, restaurants, all sorts of household services, going to out to the cinema and so on prices of these things are rising still really quickly. so yesterday we saw they were up 5.7% year on year. with that rate of increase headline inflation is not going to stay at 2% very long. at 296 very long. the next decision at 296 very long. the next decision by at 296 very long. the next decision by the at 296 very long. the next decision by the bank- at

A critical genetic database is under fire

Donors and scientists accuse GISAID of caprice and a lack of transparency

IFPMA: Biotechs, Developing Countries Vaccine Manufacturers and Pharma Unite Behind a Proposal to G20 and G7 Offering a Practical Solution for Better Access to Vaccines for Future Pandemics

The vaccines innovators and manufacturers who have produced over 15 billion COVID-19 vaccines to date are making a proposal that would ensure new vaccines developed for future global pandemics would

WTO faces tougher battle over IP waivers for Covid tests and drugs

Drugmakers charge that extending hard-won deal struck in June to include certain tests and drugs could lead to a broader unravelling of IP protections

Official response from ACT-Accelerator therapeutics partners to the IFPMA